Cladribine and Lymph follicular hypertrophy - from FDA reports


Lymph follicular hypertrophy is found among people who take Cladribine, especially for people who are male, 60+ old , have been taking the drug for 1 - 6 months, also take medication Etoposide, and have Chronic lymphocytic leukaemia. This review analyzes which people have Lymph follicular hypertrophy with Cladribine. It is created by eHealthMe based on reports of 1,058 people who have side effects when taking Cladribine from FDA , and is updated regularly.



{pitch.title}



On May, 30, 2018

1,058 people reported to have side effects when taking Cladribine.
Among them, 12 people (1.13%) have Lymph follicular hypertrophy


Number of reports submitted per year:

Could Cladribine cause Lymph follicular hypertrophy?

Time on Cladribine when people have Lymph follicular hypertrophy *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Lymph follicular hypertrophy when taking Cladribine *:

  • female: 41.67 %
  • male: 58.33 %

Age of people who have Lymph follicular hypertrophy when taking Cladribine *:

  • 0-1: 0.0 %
  • 2-9: 27.27 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 27.27 %
  • 60+: 45.45 %

Top conditions involved for these people *:

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 25.00%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 8.33%
  3. Malignant Histiocytosis (cancerous increase in the number of immune cells): 1 person, 8.33%
  4. Lymphoma (cancer that begins in immune system cells): 1 person, 8.33%
  5. Langerhans' Cell Granulomatosis: 1 person, 8.33%
Click here to get more results

Top co-used drugs for these people *:

  1. Cytarabine: 4 people, 33.33%
  2. Etoposide: 4 people, 33.33%
  3. Zevalin: 3 people, 25.00%
  4. Vinblastine Sulfate: 3 people, 25.00%
  5. Cyclophosphamide: 3 people, 25.00%
Click here to get more results

Top other side effects for these people *:

  1. Fever: 6 people, 50.00%
  2. Interstitial Lung Disease: 4 people, 33.33%
  3. Hepatomegaly (abnormal enlargement of the liver): 3 people, 25.00%
  4. Sinusitis Fungal (fungal infection of sinus): 3 people, 25.00%
  5. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 25.00%
Click here to get more results

* Approximation only. Some reports may have incomplete information.

What's next:

Do you take Cladribine and have Lymph follicular hypertrophy?



Related studies

Cladribine

Cladribine has active ingredients of cladribine. (latest outcomes from Cladribine 1,062 users)

Lymph follicular hypertrophy

Lymph follicular hypertrophy (an increase in the size of the lymph node follicles) has been reported by people with rheumatoid arthritis, multiple sclerosis, high blood pressure, psoriasis, osteoporosis (latest reports from 25,482 Lymph follicular hypertrophy patients).


Drugs that are associated with Lymph follicular hypertrophy
Lymph follicular hypertrophy (1,940 drugs)
Could your condition cause Lymph follicular hypertrophy
Lymph follicular hypertrophy (1,668 conditions)
Cladribine side effects
Browse all side effects of Cladribine
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Cladribine and have Lymph follicular hypertrophy


You are not alone. Join our personalized support groups:


You may be interested in these posts

More posts for: Cladribine, Lymph follicular hypertrophy

Recent updates

General studies
Active Support Groups
Recent Predictions
Care Guides wanted

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.